Johnson & Johnson vs ProPhase Labs, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Johnson & Johnson is the larger company by market value: $652.5 B against $87 M for ProPhase Labs, Inc., 7500 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Jan 5, 2024 for ProPhase Labs, Inc.). ProPhase Labs, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
- Johnson & Johnson had more revenue: $94.2 B against $4 M for ProPhase Labs, Inc., both in the year to December 2025.
- Johnson & Johnson made a net profit of $26.8 B, while ProPhase Labs, Inc. made a net loss of $15 M.
- Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against -339.6% for ProPhase Labs, Inc.
- Johnson & Johnson employs more people: 138,200 against 19 at ProPhase Labs, Inc. Each employee brings in about $681,570 of revenue at Johnson & Johnson and $228,421 at ProPhase Labs, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Johnson & Johnson JNJ · #23 in the world | ProPhase Labs, Inc. PRPH |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 1886 | 1989 |
| Size | ||
| Market cap | $652.5 B | $87 M* |
| Revenue | $94.2 B | $4 M |
| Net income | $26.8 B▲ best | $-15 M |
| Employees | 138,200 | 19 |
| Valuation | ||
| P/E ratio | 40.5× | — |
| Price to sales | 6.6× | — |
| Price to book | 8.0× | — |
| Free cash flow yield | 3.0% | — |
| Profitability | ||
| Gross margin | — | 31.8% |
| Operating margin | — | -415.9% |
| Net margin | — | -339.6% |
| Return on equity | — | -271.4% |
| Growth | ||
| Revenue growth | — | -35.9% |
| Revenue growth, 3 years a year | — | -67.2% |
| Financial strength | ||
| Interest cover | — | -2.6× |
| Cash | ||
| Free cash flow margin | — | -192.2% |
| Altman Z-score zone | — | — |
| Data as of | Market cap Oct 2026 | Market cap Jan 2024; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Johnson & Johnson or ProPhase Labs, Inc.?
Johnson & Johnson is the larger company by market value: $652.5 B against $87 M for ProPhase Labs, Inc., 7500 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Jan 5, 2024 for ProPhase Labs, Inc.). ProPhase Labs, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Which makes more money, Johnson & Johnson or ProPhase Labs, Inc.?
Johnson & Johnson had more revenue: $94.2 B against $4 M for ProPhase Labs, Inc., both in the year to December 2025. Johnson & Johnson made a net profit of $26.8 B, while ProPhase Labs, Inc. made a net loss of $15 M.
Which is more profitable, Johnson & Johnson or ProPhase Labs, Inc.?
Johnson & Johnson keeps more of each dollar of sales: a net margin of 28.5% against -339.6% for ProPhase Labs, Inc.
Which has more employees, Johnson & Johnson or ProPhase Labs, Inc.?
Johnson & Johnson employs more people: 138,200 against 19 at ProPhase Labs, Inc. Each employee brings in about $681,570 of revenue at Johnson & Johnson and $228,421 at ProPhase Labs, Inc.
More about Johnson & Johnson
More about ProPhase Labs, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.